These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31599014)

  • 1. Accessory mutations balance the marginal stability of the HIV-1 protease in drug resistance.
    Weikl TR; Hemmateenejad B
    Proteins; 2020 Mar; 88(3):476-484. PubMed ID: 31599014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.
    Muzammil S; Ross P; Freire E
    Biochemistry; 2003 Jan; 42(3):631-8. PubMed ID: 12534275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accessory mutations maintain stability in drug-resistant HIV-1 protease.
    Chang MW; Torbett BE
    J Mol Biol; 2011 Jul; 410(4):756-60. PubMed ID: 21762813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design.
    Velazquez-Campoy A; Muzammil S; Ohtaka H; Schön A; Vega S; Freire E
    Curr Drug Targets Infect Disord; 2003 Dec; 3(4):311-28. PubMed ID: 14754432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease.
    Vega S; Kang LW; Velazquez-Campoy A; Kiso Y; Amzel LM; Freire E
    Proteins; 2004 May; 55(3):594-602. PubMed ID: 15103623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The folding free-energy surface of HIV-1 protease: insights into the thermodynamic basis for resistance to inhibitors.
    Noel AF; Bilsel O; Kundu A; Wu Y; Zitzewitz JA; Matthews CR
    J Mol Biol; 2009 Apr; 387(4):1002-16. PubMed ID: 19150359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.
    King NM; Prabu-Jeyabalan M; Bandaranayake RM; Nalam MN; Nalivaika EA; Özen A; Haliloğlu T; Yilmaz NK; Schiffer CA
    ACS Chem Biol; 2012 Sep; 7(9):1536-46. PubMed ID: 22712830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study.
    Leonis G; Steinbrecher T; Papadopoulos MG
    J Chem Inf Model; 2013 Aug; 53(8):2141-53. PubMed ID: 23834142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV binding.
    Cai Y; Schiffer C
    Methods Mol Biol; 2012; 819():551-60. PubMed ID: 22183557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease.
    de Vera IM; Smith AN; Dancel MC; Huang X; Dunn BM; Fanucci GE
    Biochemistry; 2013 May; 52(19):3278-88. PubMed ID: 23566104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease.
    Ragland DA; Nalivaika EA; Nalam MN; Prachanronarong KL; Cao H; Bandaranayake RM; Cai Y; Kurt-Yilmaz N; Schiffer CA
    J Am Chem Soc; 2014 Aug; 136(34):11956-63. PubMed ID: 25091085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly drug-resistant HIV-1 protease reveals decreased intra-subunit interactions due to clusters of mutations.
    Kneller DW; Agniswamy J; Harrison RW; Weber IT
    FEBS J; 2020 Aug; 287(15):3235-3254. PubMed ID: 31920003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance.
    Su CT; Ling WL; Lua WH; Haw YX; Gan SK
    BMC Bioinformatics; 2016 Dec; 17(Suppl 19):500. PubMed ID: 28155724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantized water access to the HIV-1 protease active site as a proposed mechanism for cooperative mutations in drug affinity.
    Hall BA; Wright DW; Jha S; Coveney PV
    Biochemistry; 2012 Aug; 51(33):6487-9. PubMed ID: 22866962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the mechanism of drug resistance: X-ray structure analysis of G48V/C95F tethered HIV-1 protease dimer/saquinavir complex.
    Prashar V; Bihani SC; Das A; Rao DR; Hosur MV
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1018-23. PubMed ID: 20471372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes.
    Mahalingam B; Louis JM; Hung J; Harrison RW; Weber IT
    Proteins; 2001 Jun; 43(4):455-64. PubMed ID: 11340661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease.
    Ohtaka H; Velázquez-Campoy A; Xie D; Freire E
    Protein Sci; 2002 Aug; 11(8):1908-16. PubMed ID: 12142445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamical Network of HIV-1 Protease Mutants Reveals the Mechanism of Drug Resistance and Unhindered Activity.
    Appadurai R; Senapati S
    Biochemistry; 2016 Mar; 55(10):1529-40. PubMed ID: 26892689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.